Inventor
Wei Xu
Inventor
Danville, CA, US
Overview
Patents· 77 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes10%
C07CAcyclic or carbocyclic compounds7%
C05CNitrogenous fertilisers4%
C05GMixtures of fertilisers covered individually by different subclasses of class c054%
C09KMaterials for miscellaneous applications, not provided for elsewhere3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,988,598High refractive index solvent free silicone nanocomposites202110,961,398High refractive index silicone nanocomposites202110,913,901Integrated process for mesophase pitch and petrochemical production202110,889,533Inline process to make antifouling agent co-catalyst for ethylene oligomerization202110,836,743Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof202010,760,092Polypeptide and use thereof for improving stress tolerance in plants202010,660,860Therapeutic cationic peptides and unimolecular nanoparticles for efficient delivery thereof202010,633,300Compositons and methods comprising nitrification inhibitors containing a mixture of protic and aprotic solvent systems202010,597,338Liquid formulations of urease inhibitors for fertilizers202010,508,092Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them201910,464,858Non-aqueous organo liquid delivery systems containing dispersed poly (organic acids) that improve availability of macro and micro-nutrients to plants201910,329,208Liquid formulations of urease inhibitors for fertilizers201910,301,231Liquid formulations of urease inhibitors for fertilizers201910,301,230Efficiency of man-made and/or natural organic based animal manure fertilizers by liberating the bound nutrients (macro and micro) through the use of organic, non-aqueous liquid delivery formulations containing organic poly (organicacids) and/or their salts201910,273,194Process to conserve cyano-function and improve performance of low molecular weight nitrification inhibitors to improve fertilizer efficiency201910,273,211Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide201910,221,108Liquid formulations of urease inhibitors for fertilizers201910,159,666Dosing of cabozantinib formulations201810,117,836Tablet formulation for CGRP active compounds201810,035,790RORg modulators20189,732,008'Liquid formulations of urease inhibitors for fertilizers'20179,650,306'Compositions and methods comprising nitrification inhibitors containing a mixture of protic and aprotic solvent systems'20179,637,420'Increased longevity of the nitrogen content of soil through improved liquid delivery formulations of urease inhibitors and/or nitrification inhibitors designed for urea and manure based fertilizers'20178,889,664'Phosphatidylinositol 3-kinase inhibitors and methods of their use'20148,796,292'Selective antibacterials for clostridium difficile infections'20148,771,733'Pharmaceutical composition containing an anti-nucleating agent'20148,697,616'Organic molybdenum additive, its preparation method, a lubricating composition containing said additive, and use of the same'20148,642,559'C-terminal domain truncation of mGluR1α by calpain and uses thereof'20148,497,284'C-met modulators and method of use'20138,362,017'C-kit modulators and methods of use'20138,324,231'Pyrimidinones as casein kinase II (CK2) modulators'20128,242,129'6-phenylpyrimidinones as PIM modulators'20128,076,338'Kinase modulators and methods of use'20118,013,156'Tie-2 modulators and methods of use'20117,998,995'LXR and FXR modulators'20117,994,172'[1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases'20117,989,661'Human ADAM-10 inhibitors'20117,989,622'Phosphatidylinositol 3-kinase inhibitors and methods of their use'20117,951,972'Human adam-10 inhibitors'20117,816,353'P70S6 kinase modulators and method of use'20107,629,341'Human ADAM-10 inhibitors'20097,626,031'Substituted 3-(diarylmethylene)indolin-2-ones and methods of their use'20097,498,358'Human ADAM-10 inhibitors'20097,268,140'Piperazine derivatives and their use as anti-inflammatory agents'20077,202,263'N-heterocyclic derivatives as NOS inhibitors'20077,176,207'Platelet adenosine diphosphate receptor antagonists'20077,084,142'Platelet adenosine diphosphate receptor antagonists'20067,056,923'Platelet adenosine diphosphate receptor antagonists'20067,026,323'Platelet adenosine diphosphate receptor antagonists'20066,995,156'Platelet adenosine diphosphate receptor antagonists'20066,982,259'N-heterocyclic derivatives as NOS inhibitors'20066,977,258'Piperazine derivatives and their use as anti-inflammatory agents'20056,972,290'Piperazine derivatives and their use as anti-inflammatory agents'20056,926,763'Purine and isosteric antibacterial compounds'20056,924,282'Sodium salt of an HIV integrase inhibitor'20056,861,424'Platelet adenosine diphosphate receptor antagonists'20056,750,220'Amine salt of an integrin receptor antagonist'20046,686,364'Benzamidine derivatives and their use as anti-coagulants'20046,573,266'Piperazine derivatives and their use as anti-inflammatory agents'20036,555,537'Piperazine derivatives and their use as anti-inflammatory agents'20036,541,476'Piperazine derivatives and their use as anti-inflammatory agents'20036,534,509'Piperazine derivatives and their use as anti-inflammatory agents'20036,525,051'N-heterocyclic derivatives as NOS inhibitors'20036,509,347'Crystalline forms of an integrin receptor antagonist'20036,479,485'Benzamidine derivatives and their use as anti-coagulants'20026,465,459'Benzamidine derivatives and their use as anti-coagulants'20026,444,680'Amine salts of an integrin receptor antagonist'20026,350,746'Benzamidine derivatives and their use as anti-coagulants'20026,350,761'Benzenamine derivatives as anti-coagulants'20026,306,884'Benzamidine derivatives and their use as anti-coagulants'20016,207,665'Piperazine derivatives and their use as anti-inflammatory agents'20016,034,103'Benzamidine derivatives and their use as anti-coagulants'20006,004,981'Benzamidine derivatives and their use as anti-coagulants'19995,889,005'Benzamidine derivatives and their use for treating thrombotic diseases'19995,883,100'Benzamidine derivatives and their use as anti-coagulants'19995,877,181'Benzamidine derivatives and their use as anti-coagulants'19995,691,364'Benzamidine derivatives and their use as anti-coagulants'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2004Patents assigned to BERLEX LAB (12)· patent assignee history
1997–2004Based in Richmond, CA, US· patent location history
2001–2007Patents assigned to SCHERING AG (17)· patent assignee history
2001–2019Based in Danville, CA, US· patent location history
2002–2018Based in North Wales, PA, US· patent location history
2009–2019Patents assigned to EXELIXIS INC (15)· patent assignee history
2011–2019Patents assigned to XU WEI (15)· patent assignee history
2017–2019Patents assigned to MCKNIGHT GARY DAVID (6)· patent assignee history
2017–2020Based in Sugarland, TX, US· patent location history
2019–2020Based in Middleton, WI, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING AG | 17 | 2001–2007 |
| EXELIXIS INC | 15 | 2009–2019 |
| XU WEIself | 15 | 2011–2019 |
| BERLEX LAB | 12 | 1997–2004 |
| MCKNIGHT GARY DAVID | 6 | 2017–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Danville, California, US | 37 | 2001–2019 |
| Sugarland, Texas, US | 11 | 2017–2020 |
| Richmond, California, US | 11 | 1997–2004 |
| North Wales, Pennsylvania, US | 6 | 2002–2018 |
| Middleton, WI, US | 2 | 2019–2020 |